| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2518458cb1641e855357a4291a110ff0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-18 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-88 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-66 |
| filingDate |
2002-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ffca4eedbca10fdbbe96bcca2fd8fef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5af1a28e00e54e3f7b097c4aea6dd23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_634d6ac96098aa94ed620d8a1ee81326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ef881faddc5bf536fae00eed99329c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f4f43b7701199f834192b922d47f806 |
| publicationDate |
2006-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7049461-B1 |
| titleOfInvention |
Treatment of leukemia |
| abstract |
A preferred embodiment of the invention encompasses a compounds having the property of anti-carcinogenic activity against human leukemia comprising the use of 4-(4-Ethoxy-phenyl)-2-(N′-fluoren-9-ylidene-hydrazino)-2-hydroxy-4-oxo-butyric acid methyl ester (OF-13), and/or 4-Chloro-4-(4-ethoxy-phenyl)-2-(fluoren-9-ylidene-hydrazono)-but-3-enoic acid methyl ester (3F-19) in humans as therapeutic means for the eradication of leukemia from the human's body. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009016940-A1 |
| priorityDate |
2001-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |